AP-1 Transcription Factors, Mucin-Type Molecules and MMPs Regulate the IL-11 Mediated Invasiveness of JEG-3 and HTR-8/SVneo Trophoblastic Cells by Suman, Pankaj et al.
AP-1 Transcription Factors, Mucin-Type Molecules and
MMPs Regulate the IL-11 Mediated Invasiveness of JEG-3
and HTR-8/SVneo Trophoblastic Cells
Pankaj Suman
1, Geeta Godbole
2, Ravi Thakur
1, Diana M. Morales-Prieto
3, Deepak N. Modi
2, Udo R.
Markert
3, Satish K. Gupta
1*
1Reproductive Cell Biology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India, 2National Institute for Research in Reproductive Health,
Jehangir Merwanji Street, Parel, Mumbai, India, 3Placenta Laboratory, Department of Obstetrics, Faculty of Medicine, Friedrich-Schiller University, Jena, Germany
Abstract
This study examines the IL-11 mediated activation of downstream signaling and expression of effector molecules to resolve
the controversies associated with the IL-11 mediated regulation of the invasiveness of two commonly used trophoblastic
cell models viz. JEG-3 and HTR-8/SVneo cells. It has been reported that IL-11 increases the invasiveness of JEG-3 cells while,
reduces the invasiveness of HTR-8/SVneo cells. Invasion assay performed simultaneously for both the cell lines confirmed
the above findings. In addition, HTR-8/SVneo cells showed a higher basal invasiveness than JEG-3 cells. Western blot
showed the IL-11 mediated activation of STAT3(tyr705) and STAT1(tyr701) in both the cell lines. However, IL-11 activated the
ERK1/2 phosphorylation in JEG-3 cells but, inhibited it in HTR-8/SVneo cells. Within 10 min of IL-11 treatment, p-
STAT3(tyr705) was localized inside the nucleus of both the cell lines but, there was enhanced co-localization of protein
inhibitor of activated STAT1/3 (PIAS1/3) and p-STAT3(tyr705) in HTR-8/SVneo cells and not in JEG-3 cells. This could be
reason for the poor responsiveness of STAT3 responsive genes like mucin 1 (MUC1) in HTR-8/SVneo cells and not in JEG-3
cells. Further, microarray analysis of the IL-11 treated cells revealed differential responsiveness of JEG-3 as compared to HTR-
8/SVneo cells. Several family of genes like activator protein-1 (AP-1) transcription factors (Jun and Fos), mucin-type
molecules, MMP23B etc showed enhanced expression in IL-11 treated JEG-3 cells while, there was no response or decrease
in their expression in IL-11 treated HTR-8/SVneo cells. Expression of these molecules was confirmed by quantitative RT-PCR.
In addition, HTR-8/SVneo cells also showed a significant decrease in the expression of MMP2, MMP3 and MMP9 upon IL-11
treatment. Hence, IL-11 mediated differential activation of signaling and expression of effector molecules is responsible for
the differential invasive response of JEG-3 and HTR-8/SVneo cells.
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Introduction
Invasion of trophoblast cells is one of the critical events
associated with the embryo implantation as it helps in establishing
the exquisite contact between the fetus and the maternal
circulation. Aberration in invasive behavior of the trophoblast
cells may lead to several pathological conditions which may range
from pre-eclampsia (due to shallow implantation) to placental bed
tumors (due to excessive invasion) [1,2]. Several cytokines and
growth factors present at the implantation site regulate the spatial
and temporal invasion of the trophoblast cells either by acting in
autocrine or paracrine manner to achieve successful conception
[3].
IL-11, a member of the IL-6 family, is present at the site of
implantation and has been observed to be indispensable for the
embryonic development [4]. The IL-11 receptor a (IL-11Ra)
knockout female mice, are infertile because of defective decid-
ualization of the endometrial stromal cells [5,6]. In humans, IL-
11Ra is consistently expressed in the endometrium from
proliferative and secretory phase to 7–9 weeks of gestation [7].
In contrast to this, IL-11 expression is barely detectable in the
proliferative and secretory phase of endometrium but, its
expression is significantly higher in the chorionic villi as well as
in the decidua [5]. Further, defective production of IL-11 is
associated with reduced fertility rate in human pregnancy [5].
Additionally, plasma level of IL-11 was low in women with
spontaneous abortion [8].
Though, IL-11 plays a defined role in endometrial decidualiza-
tion, its role in trophoblastic cell invasion has been held in
controversy. Exogenous treatment of JEG-3 choriocarcinoma cells
with IL-11 led to an increase in invasion [9]. The increase in the
invasiveness of JEG-3 choriocarcinoma cells was associated with
the activation of signal transducer and activator of transcription 3
(STAT3) as well as of STAT1 and extracellular signal regulated
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(co-receptor for the IL-11 mediated signaling) expression in JEG-3
cells inhibits the IL-11 mediated increase in JEG-3 cells invasion
[9]. However, using extra villous trophoblast (EVT) cells and
HTR-8/SVneo cells (derived from human first trimester placenta
explant cultures immortalized by SV40 large T antigen) as a
trophoblast cell model, it was shown that, IL -11 reduces their
invasiveness in spite of the activation of STAT3 dependent
signaling pathway [10]. This decrease in invasiveness of HTR-8/
SVneo cells was not associated with any significant changes in the
expression of classical invasion associated molecules like matrix
metalloproteinase 2 (MMP2), MMP9, tissue inhibitor of metallo-
proteinase 1 (TIMP1), TIMP2, TIMP3, plasminogen activator
urokinase (PLAU), plasminogen activator urokinase receptor
(PLAUR), and serpin peptidase inhibitors 1 and 2 (SERPINE1
and SERPINE2) [10]. Thus, the reason for inhibition of invasion
of HTR-8/SVneo cells in response to IL-11 is not known.
The existing studies leaves behind several key questions which
need to be addressed to resolve the ambiguities associated with the
differential responsiveness of JEG-3 and HTR-8/SVneo cells
towards the IL-11 treatment. 1) Are there differences in the IL-11
mediated activation of the downstream signaling in JEG-3 and
HTR-8/SVneo cells? 2) What are the effector molecules whose
alterations in response to IL-11 can explain the respective increase
and decrease in the invasiveness of JEG-3 and HTR-8/SVneo
cells? Keeping these key questions in mind, present study has been
designed to provide evidences for the differential regulation of IL-
11 mediated invasiveness of JEG-3 and HTR-8/SVneo cells.
Materials and Methods
Cell culture
JEG-3 (German collection of cell lines and microorganisms;
DZMO, Braunschweig, Germany) and HTR-8/SVneo (kindly
provided by Dr. Charles Graham, Queen’s University, Kingston,
ON, Canada) cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM; Sigma-Aldrich Inc., St. Louis, MO,
USA) or RPMI-1640 (Sigma-Aldrich Inc.) medium respectively,
supplemented with 10% Fetal Bovine Serum (FBS; Biological
Industries, Kibbutz beit Haemek, Israel) and an antibiotic-
antimycotic cocktail [Penicillin (100 units/ml), Streptomycin
(100 mg/ml) and Amphotericin B (0.25 mg/ml); Pen-Strep-Ampho
sol, Biological Industries] under 5% CO2 humidified atmosphere
at 37uC [11].
Invasion assay
Invasion assay was performed as described before [9]. Briefly,
,10
5 cells were seeded onto the Matrigel matrix and incubated
with or without an optimized concentration of IL-11 (200 ng/ml;
Peprotech, Rocky Hill, NJ, USA) [9]. After 24 h of incubation,
Table 1. Primer sequences used for the real-time PCR.
Gene Primers Annealing temperature Product size (bps)
Integrin aVF : 5 9 GCTCCATCTTCAGTGCCCTTA 39
R: 59 TTGGCAGACAATCTTCAAGCA 39
60uC2 7 4
Integrin a5F : 5 9 CGCAGCTCTGCTTCCTCGGG 39
R: 59 GCTGTGGCCACCTGACGCTC 39
60uC2 6 0
Integrin a6F : 5 9 TGCAGGCACTCAGGTTCGAGTGA 39
R: 59 AGCATGGTATCGGGGAACACTGTCA 39
60uC1 9 3
MMP2 F: 59 ACCGCAAGTGGGGCTTCTGC 39
R: 59 CGTGGCCAAACTCGTGGGCT 39
60uC7 2
MMP3 F: 59 TTGGCCCATGCCTATGCCCC 39
R: 59 ACAGGCGGAACCGAGTCAGG 39
57uC2 1 4
MMP9 F: 59 CCGGCATTCAGGGAGACGCC 39
R: 59 TGGAACCACGACGCCCTTGC 39
61uC7 1
MMP23B F: 59 GCTGGTCGCCCTGTGCCTC 39
R: 59 GGAGTCAGCGTGTAGCGGCG 39
60uC1 7 7
TIMP1 F: 59 TGACATCCGGTTCGTCTACA 39
R: 59 GTTTGCAGGGGATGGATAAA 39
62uC2 4 8
TIMP2 F: 59 GATGCACATCACCCTCTGTG 39
R: 59 GTGCCCGTTGATGTTCTTCT 39
62uC1 9 6
TIMP3 F: 59 CTGACAGGTCGCGTCTATGA 39
R: 59 AGTCACAAAGCAAGGCAGGT 39
60uC1 6 5
18S F 59 GGAGAGGGAGCCTGAGAAAC 39
R5 9 CCTCCAATGGATCCTCGTTA 39
60uC1 7 1
Jun F 59 AGAGCGGTGCCTACGGCTACAGTAA 39
R5 9 CGACGTGAGAAGGTCCGAGTTCTTG 39
60uC1 2 5
Fos F: 59 ATGGGCTCGCCTGTCAACGC 39
R: 39 GGAGATAACTGTTCCACCTTGCCCC 39
60uC2 8 4
MUC1 F: 59 GTG CCC CCT AGC AGT ACC GA 39
R: 59 GAC GTG CCC CTA CAA GTT GG 39
60uC1 2 3
PDPN 1/3 F: 59 AGCACAGTCCACGCGCAAGA 39
R: 59 CTTTAGGGCGAGTACCTTCCCGACA 39
58uC1 6 8
PDPN 2/4 F: 59 GCCACCAGTCACTCCACGGAGAA 39
R: 59 GGGCCTTCCCGACATTTTTCGC 39
58uC2 3 0
doi:10.1371/journal.pone.0029745.t001
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and Matrigel on the top of membrane of the transwell inserts were
removed using moist cotton swab. Cells from the lower side of the
membrane were fixed by chilled methanol for 7–10 min at 4uC,
followed by staining with 0.2 mM Hoechst 33342 nuclear dye
(Biotium Inc., Hayward, CA, USA) for 5 min at 37uC, washed
with 50 mM PBS; pH 7.4 and visualized for counting using the
fluorescent phase contrast microscope (Eclipse 80i, Nikon,
Chiyoda Ku, Japan) under oil immersion.
Preparation of whole cell extract
Cells (10
5) were cultured in six well culture plates for 24 h and
starved of FBS for at least 4 h before treatment with IL-11
(200 ng/ml) for 10, 30 and 60 min or for 24 h in the serum free
medium. After each time point, the medium was aspirated and
cells were lysed in 100 ml of lysis buffer (20 mM Tris-HCl, 10%
glycerol, 0.2 mM EDTA, 0.137 M NaCl, 1% NP-40) supple-
mented with Complete protease and phosphatase inhibitor
cocktail (Roche Diagnostics GmbH, Mannheim, Germany). This
was followed by 3 rapid freeze and thaw cycles to ensure the
complete lysis of the cells. Cell lysates were centrifuged at 12,0006
g for 10 min at 4uC and the supernatant was collected. The
amount of protein in each sample was quantitated by BCA
colorimetric assay using bovine serum albumin (BSA) as standard.
Western blot
About 40 mg of cell extract was electrophoressed and transferred
onto the nitrocellulose membrane as described before [9].
Individual blots were incubated at 4uC overnight with 1:1000
dilution of rabbit polyclonal antibodies against phospho-STAT1
(p-STAT1)(tyr701), p-STAT3(tyr705), p-STAT3(ser727), p-
ERK1/2(thr202/204), STAT1, STAT3 (All from Cell Signaling
Technology Inc., Danvers, MA, USA) and mouse monoclonal
antibody against ERK1/2 (Abcam, Cambridge, MA, USA)
followed by incubation with 1:2000 dilution of HRP conjugated
goat anti-rabbit/mouse IgG antibody (Pierce, Rockford, IL, USA)
for 1 h at room temperature (RT). Intensity of bands on Western
blots were quantified by LabWorks Software Version 4.5 (Ultra-
Violet Products Ltd., Cambridge, UK).
In another set of experiment, cell lysates (,40 mg) prepared
after 24 h of IL-11 (200 ng/ml) treatment to either JEG-3 or
HTR-8/SVneo cells were resolved by SDS-PAGE and transferred
onto the nitrocellulose membrane as described above. Blots were
probed overnight at 4uC with goat polyclonal antibody against
protein inhibitor of activated STAT 1/3 (PIAS1/3; 1:1000
dilution; Santa Cruz Biotechnology, Inc. Santa Cruz, CA, USA)
followed by HRP conjugated donkey anti-goat IgG antibodies
(1:2000 dilution) for 1 h at RT. Blots were developed by
chemiluminescent substrate and further re-probed for actin as
described before [9].
Quantitative real-time reverse transcription-polymerase
chain reaction (qRT-PCR)
Cells (,10
5) were seeded onto the 6 well culture plate and
cultured for 24 h. Cell were serum starved for 4 h before addition
of IL-11 (200 ng/ml) for 24 h, keeping appropriate vehicle
control. Total RNA was isolated from cells using Tri reagent
(Sigma-Aldrich Inc.) following the standard protocol employing
chloroform-isopropanol-ethanol steps for its purification. Isolated
RNA samples were quantitated by NanoDrop 3300 spectropho-
tometer (Thermo Scientific, NanoDrop Products, Wilmington,
DE, USA) and were subjected to DNase I (Ferments International
Inc., Ontario, Canada) treatment at 37uC for 15 min as per the
manufacturer’s instruction. The isolated RNA (1 mg) was used to
prepare the cDNA using random hexamers, dNTP mixture, RT
buffer and Superscript III reverse transcriptase following the
manufacturer’s protocol (Superscript III RT PCR System;
Invitrogen, Carlsbad, CA, USA). qRT-PCR reactions were
carried out in triplicates in 20 ml reaction mixture containing
Maxima
TM SYBR green qPCR master mix (26) (Ferments
International Inc.), synthesized cDNA and gene specific primers
(1 nm) on an ABI 7500 machine (Life Technologies Corp.,
Carlsbad, CA, USA). The primers used for real-time PCR and
their respective annealing temperatures are listed in Table 1. The
temperature profiles used for the amplification of target sequences
were: initial denaturation for 95uC for 10 min, followed by 40
cycles of 95uC for 15 sec, amplification for 1 min at primer
specific annealing temperature value (Table 1) and then a final
melting curve analysis with a range from 60 to 95uC over 20 min.
Gene-specific amplification was confirmed by a single peak in the
ABI Dissociation Curve software. Average threshold cycle (Ct)
values for 18S rRNA (run in parallel reactions to the genes of
interest) were used to normalize average Ct values of the gene of
interest. These values were used to calculate the average for each
group, and the relative DCt was used to determine the change in
expression between the groups.
Microarray
Total RNA was extracted using Tri reagent (Sigma Aldrich Inc.)
and purified on RNeasy columns (Qiagen, Crawley, UK)
according to the manufacturers recommendations. RNA quality
was checked using an Agilant 2100 Bioanalyser (Agilent
Technologies, Palo Alto, USA). Sense strand cDNA was prepared
using the Ambion WT expression kit (Ambion Inc., Austin, Texas,
USA) which was fragmented and biotin-labeled using the
Figure 1. Effect of IL-11 on invasion of JEG-3 and HTR-8/SVneo
cells. Invasion assay was performed as mentioned in Materials and
Methods. Data is expressed as fold change in invasion following IL-11
(200 ng/ml) treatment as compared to untreated JEG-3 cells as control.
Values are expressed as mean 6 SEM of at least 6 experiments
performed in duplicates. *p,0.05; **p,0.001.
doi:10.1371/journal.pone.0029745.g001
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Wycombe, UK) according to manufacturers’ recommendations.
Fragmented and labeled cDNAs were hybridized to Affymetrix
Exon 1 ST GeneChips (Affymetrix) at 45uC for 17 h in
hybridization oven at 60 rpm according to Affymetrix protocols
(Affymetrix). The washing and staining were performed using the
Affymetrix Fluidics Station 450. The chips were read using a
GeneChip Scanner 3000, and the resulting raw image was
converted to signal intensities, detection calls, comparison files,
signal log ratios, and change calls (Center for Genomic
Application, New Delhi, India). Each of these pieces of data was
generated independent of each other using algorithms from the
Affymetrix GenChip Operating Software. For normalizing and
summarizing probe-level intensity measurements from Gene-
Chips, GCRMA was used which converts .CEL files into
expression set using the Robust Multi-array Average (RMA) with
the help of probe sequence and with GC-content background
correction. Statistical (Student’s t test) analysis was performed with
Affymetrix Data Mining Tool software. The data were filtered on
the criteria of 1.5 fold up- or 0.5 fold down-regulation taking into
account the genes whose p,0.05. Basic information related to the
microarray data has been submitted to the GEO database
following the MIAME guidelines (Accession no. GSE31608).
Silencing of matrix metalloproteinase 23B (MMP23B)
expression by siRNA
MMP23B siRNA contains the smart pool of 3 different siRNAs
(Thermo Scientific Dharmacon, Lafayette, CO, USA). Cells were
cultured in 6 well plates under standard conditions (37uC, 5%
CO2 humidified atmosphere). At 50% confluency, cells were
washed twice with OPTI-MEM I medium and 800 mlo ff r e s h
OPTI-MEM I medium was added into each well. Annealed
oligonucleotides (final concentration 100 nm) were mixed with
OPTI-MEM I to make a total volume of 185 ml. In a separate
tube, 4 ml lipofectamine 2000 was mixed with 11 ml OPTI-MEM
I medium. Both the solutions were mixed and incubated for
20 min at RT. The mixed solutions were added carefully drop by
drop in respective wells and after 4 h of incubation, complete
medium was added to the cells in each well. Silencing
experiments were performed by keeping transfection (transfected
with non-genomic siRNA) controls. The extent of silencing
following transfection with siRNA was accessed by RT-PCR after
72 h of silencing.
Immunofluorescence
Cells (,2610
4) were grown on the cover slips in 24 well cell
culture plates for 24 h. After 4 h of serum starvation, cells were
Figure 2. Activation of STAT and ERK1/2 dependent signaling pathway following IL-11 treatment. JEG-3 and HTR-8/SVneo cells were
treated with IL-11 (200 ng/ml) for varying period of time and Western blots were done as mentioned in Materials and Methods. Panels A, B, C and D
represent the densitometric plots of p-STAT3(tyr705), p-STAT3(ser727), p-STAT1(tyr705) and p-ERK1/2 respectively. Band intensities were normalized
with respect to respective unphosphorylated proteins and the data is expressed as fold change with respect to JEG-3 control. The data is shown as
mean 6 SEM of at least 3 experiments.
#p,0.001 between un-treated JEG-3 and HTR-8/SVneo cells; *p,0.05 with respect to respective un-treated
control cells.
doi:10.1371/journal.pone.0029745.g002
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and fixed with chilled methanol for 5 min at 4uC. Cells were
washed with 50 mM PBS; pH 7.4 and blocking was done for 1 h
at RT using PBS containing 2% BSA. Cells were washed and
incubated overnight at 4uC with rabbit polyclonal antibody
against p-STAT3(tyr705) (1:100 dilution) and goat polyclonal
antibody against PIAS1/3 (1:100 dilution). This was followed by
washing of the cells with PBS for 3 times and incubation with
1:400 dilutions of Alexa Fluor 488 goat anti-rabbit IgG (H+L) and
donkey anti-goat IgG-rhodamine for 1 h at RT to perform the
double labeling. Cells were again washed with PBS (4 times) and
mounted in dark onto the glass slide using Vectashield hard set
mounting medium containing DAPI (1.5 mg/ml) (Vector Labora-
tories Inc., Burlingame, CA, USA). Slides were screened for
immunofluorescence under a fluorescent phase contrast micro-
scope (Nikon) and images were captured by using the Image
Proplus software (Nikon).
Statistical analysis
All the experiments were performed at least three times and the
results are expressed as mean 6 SEM. For different sets of
experiments like invasion assay and Western blot (densitometric
analysis), the statistical analysis was done by comparing the means
of the control and experimental sets by one-way ANOVA. A value
of p,0.05 was considered to be statistically significant.
Results
Invasion of JEG-3 and HTR-8/SVneo cells under the
influence of IL-11
At the basal level, a significantly higher (,12 fold; p,0.001)
invasiveness of HTR-8/SVneo cells as compared to JEG-3 cells
was observed (Fig. 1). As compared to untreated cells, almost five
fold increase in invasion was observed in response to optimized
concentration of IL-11 (200 ng/ml) in JEG-3 cells while, at the
same concentration, IL-11 inhibited invasion of HTR-8/SVneo
cells to almost half (p,0.05; Fig. 1).
Activation of downstream signaling molecules by IL-11 in
JEG-3 and HTR-8/SVneo cells
JEG-3 and HTR-8/SVneo cells were treated with IL-11
(200 ng/ml) for varying time periods (0, 10, 30 and 60 min) and
cell lysates collected at specific time points were subjected for
Western blot. There was a significantly higher (p,0.05) basal
levels of p-STAT3(tyr705) (Fig. 2A), p-STAT3(ser727) (Fig. 2B)
and p-ERK1/2 (Fig. 2C) in HTR-8/SVneo cells as compared to
JEG-3 cells but, no differences were observed in the levels of p-
STAT1(tyr701) in both the cell lines (Fig. 2D).
As compared to untreated controls, following IL-11 treatment
there was an increase in the activation of STAT3(tyr705) in both
JEG-3 and HTR-8/SVneo cells, which was evident as early as
10 min and continued until 60 min of IL-11 challenge (Fig. 2A).
However, no significant changes in the phosphorylation of
STAT3(ser727) was observed in both the cells at all the time
points studied (Fig. 2B). IL-11 treatment to JEG-3 and HTR-8/
SVneo cells led to a significantly higher (p,0.05) phosphorylation
of STAT1(tyr701) (Fig. 2C).
In JEG-3 cells, following IL-11 treatment, there was a
significant increase (p,0.05) in activation of ERK1 by 10 and
30 min which was still far less than the basal level of activated
ERK1 in HTR-8/SVneo cells (Fig. 2D). However, IL-11
treatment to HTR-8/SVneo cells led to a significant decrease
(p,0.05) in the activated ERK1 and ERK2 from the basal level by
10 and 30 min (Fig. 2D).
Microarray analyses of the IL-11 treated JEG-3 and HTR-8/
SVneo cells
JEG-3 and HTR-8/SVneo cells were treated with IL-11
(200 ng/ml) for 24 h and microarray analysis was carried out as
Figure 3. IL-11 mediated expression of Jun and Fos in JEG-3 and HTR-8/SVneo cells. Quantitative RT-PCR was done for the expression of
Jun (Panel A) and Fos (Panel B) as mentioned in Materials and Methods. Each bar represents the DCt values after normalization with the 18S rRNA. The
data is expressed as mean 6 SEM of 3 experiments performed in triplicates. *p,0.05; **p,0.001.
doi:10.1371/journal.pone.0029745.g003
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Human Exon 1.0 ST (Affymetrix, Santa Clara, CA) for these
experiments. The array contains over 1.4 million probe sets and
over 5 million probes. The probe sets are grouped into over
300,000 transcript clusters with over 90,000 transcript clusters
containing more than one probe set. As compared to untreated
controls, following IL-11 treatment to JEG-3 and HTR-8/SVneo
cells, some distinct set of genes got up- and down- regulated. In
JEG-3 cells, upon IL-11 treatment, 314 genes got upregulated by
at least 1.5 fold while, 313 got downregulated by 0.5 fold. In
contrast to this, in HTR-8/SVneo cells, 75 genes showed
upregulation by at least 1.5 fold while, 54 showed downregulation
by at least 0.5 fold following IL-11 treatment. Out of these, there
were genes like MMP23B, Jun, secretogranin II, dual specificity
phosphatase 6, Wnt5A, homeobox A6, IL-1f and syntaxin 11, which
showed an increase in their expression in IL-11 treated JEG-3 cells
while, a decrease in their expression was observed in IL-11 treated
HTR-8/SVneo cells. Treatment of JEG-3 cells with IL-11 also led
to an increase in the expression of genes like mucin 1, cadherin 13
(CDH13), defensin b1, insulin like growth factor binding protein 2 (IGFBP2)
and IGFBP5, whose expression were not significantly altered in
HTR-8/SVneo cells. Validation of some of the leads gained after
microarray analysis have been carried out by performing qRT-
PCR analysis on the RNA samples isolated from IL-11 treated
JEG-3 and HTR-8/SVneo cells.
After this, we performed a comparative analysis of the gene
expression in JEG-3 and HTR-8/SVneo cells. As compared to
JEG-3 cells, in HTR-8/SVneo cells, there were about 1176 genes,
which showed at least 2 fold increase while, about 1334 genes
showed about 2 fold decrease in their expression. Amongst the
differentially expressed genes, there were several molecules whose
expression might influence the invasive capabilities of a given cell
type. As compared to JEG-3 cells, HTR-8/SVneo cells showed
over-expression of proteases [MMP1, MMP2, MMP9, MMP23B,
tissue palsminogen activator (TPA), PLAUR], protease inhibitor like
TIMP1, adhesion molecules [CDH13, CDH2, integrin A2 (ITGA2),
ITGA3, ITGA4, ITGA11, MUC1, syndecan 2 (SDC2)], cytokines or
their receptors (IL-11, IL-32, IL-27A, MCSF1, IL-8, IL-1b, LIFR,
NOTCH2) and signaling intermediates [Janus kinase 2 (JAK2),
STAT3, suppressor of cytokine signaling 3 (SOCS3), SOCS5, human
homologue of mothers against decapentaplegic 9 (SMAD9)]. However, there
were several molecules like MMP14, MMP19, TIMP4, CDH1(E-
cadherin), CDH3 (placental cadherin),CDH5, CDH8, protocadherin beta 13,
ITGB4, MUC15, CDH18, insulin like growth factor 2 (IGF2), STAT1,
FOS, SP6 transcription factor (SP6) etc that showed a higher expression
in JEG-3 cells as compared to HTR-8/SVneo cells.
Further, on the basis of the observed differences at the level of
gene expression, we carried out pathway analysis by using DAVID
functional annotation tool (DAVID Bioinformatics Resources 6.7,
NIAID/NIH, USA) [12,13]. HTR-8/SVneo cells showed an
over-expression of molecules associated with signaling pathways
which promote the invasiveness of cells. These were MAPK
signaling pathway, pathways in cancer, cytokine-cytokine receptor
interaction, focal adhesion, chemokine signaling, ECM-receptor
interaction, transforming growth factor b (TGF b) signaling
pathway etc. As compared to HTR-8/SVneo cells, JEG-3 cells
showed an increase in the expression of molecules associated with
signaling pathways like renal cell carcinoma, thyroid cancer,
insulin signaling, P53 signaling, tight junction etc.
Effect of IL-11 on the expression of activator protein-1
(AP-1) transcription factors
Jun and Fos are two main members of the AP-1 transcription
factor. Microarray of IL-11 treated JEG-3 and HTR-8/SVneo
cells suggested the upregulation of Jun expression in JEG-3 cells
while, downregulation in HTR-8/SVneo cells. To further validate
this observation, qRT-PCR was performed in IL-11 treated JEG-3
and HTR-8/SVneo cells. At the basal level, HTR-8/SVneo cells
showed a significantly higher (p,0.001) level of Jun expression
than that of the JEG-3 cells (Fig. 3A). Further, IL-11 treatment
significantly increased the expression of Jun in JEG-3 cells while,
the increase in its expression in HTR-8/SVneo cells was not
significant (Fig. 3A). Analysis of the expression of Fos (one of the
closely associated partners of Jun) was also carried out by qRT-
PCR. Unlike Jun, at the basal level, there was a significantly higher
(P,0.001) expression of Fos in JEG-3 cells as compared to HTR-
8/SVneo cells (Fig. 3B). Treatment of JEG-3 cells with IL-11 led
to a significantly higher (p,0.05) level of Fos expression while,
there was a significant decrease (p,0.05) in the expression of Fos
in HTR-8/SVneo cells (Fig. 3B).
Figure 4. IL-11 mediated expression of MUC1 and PDPN in JEG-
3 and HTR-8/SVneo cells. Quantitative RT-PCR was done for the
expression of MUC1 (Panel A) and PDPN (Panel B) as mentioned in
Materials and Methods. Each bar represents the DCt values after
normalization with the 18S rRNA. The data is expressed as mean 6 SEM
of 3 experiments performed in triplicates. *p,0.05; **p,0.001.
doi:10.1371/journal.pone.0029745.g004
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glycoproteins (mucin 1 and podoplanin) in JEG-3 and
HTR-8/SVneo cells
Microarray analysis suggested an upregulation in the expres-
sion of MUC1 in IL-11 treated JEG-3 cells while, its downreg-
ulation in IL-11 treated HTR-8/SVneo cells. This observation
was confirmed by performing the qRT-PCR on the RNA
samples isolated from JEG-3 and HTR-8/SVneo cells treated
with IL-11 for 24 h. We observed an increase (p,0.05) in the
expression of MUC1 in IL-11 treated JEG-3 cells (Fig. 4A).
However, decrease in the expression of MUC1 in IL-11 treated
HTR-8/SVneo cells was not statistically significant (Fig. 4A).
Podoplanin (PDPN) is another mucin-like protein which is
expressed as four splice variants. Though, its expression was
not significantly altered in the microarray data but, considering
its significance in the LIF mediated increase in invasion of
trophoblast cells (unpublished data), qRT-PCR was performed to
analyze the changes in its expression in IL-11 treated JEG-3 and
HTR-8/SVneo cells. To analyze the expression of all the four
splice variants, two sets of PCR primers were made for qRT-PCR
(Table 1). As observed for MUC1, HTR-8/SVneo cells had a
significantly higher (p,0.001) level of basal expression of PDPN
than that of JEG-3 cells (Fig. 4B). Further, IL-11 treatment
increased (p,0.05) the expression of PDPN in JEG-3 cells while;
there was no significant change in the expression of PDPN in IL-
11 treated HTR-8/SVneo cells (Fig. 4B).
Figure 5. Role of MMP23B in IL-11 mediated invasion of JEG-3 and HTR-8/SVneo cells. Quantitative RT-PCR was done for the expression of
MMP23B (Panel A) as mentioned in Materials and Methods. Each bar represents the DCt values after normalization with the 18S rRNA. The data is
expressed as mean 6 SEM of 3 experiments performed in triplicates. In another experiment, JEG-3 cells were transfected with either MMP23B siRNA
or non-genomic siRNA for 72 h and end point RT-PCR was done to check the level of silencing in them, keeping 18S rRNA as internal control (Panel B).
The transfected cells were used to study their invasive behavior in the presence or absence of IL-11 (200 ng/ml) as described in Materials and
Methods. The results are expressed as mean 6 SEM of fold change in invasion as compared to non-genomic siRNA transfected cells in the absence of
IL-11, observed in 3 independent experiments. *p,0.05; **p,0.001; #p,0.01 between JEG-3 cells transfected with non-genomic and MMP23B
siRNA;
$p,0.001 between IL-11 treated non-genomic siRNA transfected and MMP23B siRNA transfected JEG-3 cells.
doi:10.1371/journal.pone.0029745.g005
Table 2. Effect of IL-11 on the expression of MMPs, TIMPs and
integrins.
Gene JEG-3 HTR-8/SVneo
Control IL-11 Control IL-11
MMP2 160.23 1.360.29 39.4614.4
# 14.466.2*
MMP3 160.34 0.860.56 19.367.18
# 1.660.17*
MMP9 160.3 1.2160.44 217.3642.6
# 83.5619.6*
TIMP1 160.12 1.460.59 13967.00
# 111625.00
TIMP2 160.38 0.960.03 3.560.30
# 2.261.00
TIMP3 160.39 0.960.03 0.960.07 0.660.35
Integrin a5 160.45 1.160.10 2.961.55
# 2.961.25
Integrin a6 160.24 0.760.15 0.960.05 0.660.04
Integrin aV 160.32 1.260.19 0.660.01 0.460.01
For each sample, DCt values were obtained after normalization with the Ct
values for 18S rRNA. After that fold change in expression (DCt values) between
the groups was calculated with respect to the untreated JEG-3 cells.
#p,0.001 between untreated JEG-3 and HTR-8/SVneo cells;
*p,0.05 between un-stimulated and IL-11 treated HTR-8/SVneo cells.
doi:10.1371/journal.pone.0029745.t002
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while, decreases its expression in HTR-8/SVneo cells
Microarray analysis of the IL-11 treated JEG-3 and HTR-8/
SVneo cells showed an increase in the expression of MMP23B in
JEG-3 cells while, a decrease in its expression in HTR-8/SVneo
cells. To validate this observation, expression of MMP23B was
analysed by qRT-PCR in RNA samples isolated from IL-11
treated JEG-3 and HTR-8/SVneo cells. In HTR-8/SVneo cells,
there was a significantly higher basal expression (p,0.001) of
MMP23B as compared to JEG-3 cells (Fig. 5A). Upon IL-11
treatment to JEG-3 cells, there was a significant increase in the
MMP23B expression while, in HTR-8/SVneo cells, IL-11
significantly reduced (P,0.05) its expression (Fig. 5A).
Silencing of MMP23B expression abrogates the IL-11
mediated increase in JEG-3 cell invasion
To determine the significance of the increase in MMP23B
expression in IL-11 mediated increase in invasive behavior of JEG-
3 cells, its expression was silenced using siRNA. There was more
than 70% silencing of the expression of MMP23B after 72 h of
transfection with siRNA (Fig. 5B). Upon IL-11 treatment, there
was a significant increase (p,0.05) in the invasiveness of non-
genomic siRNA transfected cells (Fig. 5C). However, silencing of
MMP23B expression by siRNA led to a significant decrease in the
invasiveness of JEG-3 cells as compared to non-genomic siRNA
transfected cells. Treatment of MMP23B silenced JEG-3 cells with
IL-11 did not lead to a significant change in the invasion as
compared to the control cells (Fig. 5C).
Expression of MMPs and TIMPs in JEG-3 and HTR-8/
SVneo cells following IL-11 treatment
Expression of MMP2, 3, 9 and TIMP1, 2 and 3 was analysed in
JEG-3 and HTR/SVneo cells after 24 h of IL-11 treatment. In
JEG-3 cells, there were no significant changes in the expression of
these MMPs upon IL-11 treatment while, in HTR-8/SVneo
cells, IL-11 treatment brought a significant decrease (p,0.05) in
the expression of MMP2, 3 and 9 (Table 2). There were no
significant changes in the expression of TIMPs in IL-11 treated
JEG-3 and HTR-8/SVneo cells. At the basal level, HTR-8/
SVneo cells had a significantly higher expression of MMP2,
MMP3, MMP9, TIMP1 and TIMP2 than that of the JEG-3 cells
(Table 2).
IL-11 mediated expression of integrins and other
adhesion molecules in JEG-3 and HTR-8/SVneo cells
Switching in the expression of integrins like integrin a5, aV and
a6 have been observed during the invasive differentiation of
trophoblast cells. At the basal level, the expression of integrin a5
was significantly higher (p,0.01) in HTR-8/SVneo cells as
compared to JEG-3 cells (Table 2). However, following IL-11
treatment no significant change in the expression of integrin a5, aV
and a6 were observed in both the cell lines as compared to
respective controls (Table 2).
IL-11 decreases the expression of PIAS1 but, not of PIAS3
in HTR-8/SVneo cells
Western blots were performed for the analysis of PIAS1/3
expression in the cell lysates prepared after treatment of JEG-3
and HTR-8/SVneo cells with IL-11 for 24 h. At the basal level,
both the cell lines expressed the PIAS1 while, PIAS3 was
expressed only by HTR-8/SVneo cells. The level of expression
of PIAS3 in JEG-3 cells was almost negligible as compared to
HTR-8/SVneo cells. Upon IL-11 treatment, there was a
significant decrease (p,0.05) in the expression of PIAS1 in
HTR-8/SVneo cells while, there was no significant change in the
expression of PIAS3 as compared to the control (Fig. 6). However,
no significant changes in their expression were observed in JEG-3
cells after IL-11 treatment (Fig. 6).
IL-11 treatment to HTR-8/SVneo cells leads to nuclear
co-localization of PIAS1/3 and p-STAT3(tyr705)
PAIS3 is a potential negative regulator of STAT3 signaling. If
bound with the activated STAT3 molecules, PIAS3 can interfere
with its transcriptional activity. To observe the IL-11 mediated
nuclear localization of p-STAT3(tyr705) and its transcriptional
activity which might get interfered by PIAS3, JEG-3 and HTR-
8/SVneo cells were treated with IL-11 for 10 min and
immunostained for p-STAT3(tyr705) and PIAS1/3. In untreated
JEG-3 cells, fluorescence signal for PIAS1/3 was distributed
throughout the cytoplasm and nucleus along with a typical
punctate staining of PIAS1/3 at the cell boundary which would
correspond to PIAS1 as JEG-3 cells have feeble expression of
PIAS3 (Fig. 7). In untreated JEG-3 cells, there was no
fluorescence signal for p-STAT3(tyr705) (Fig. 7). Upon treatment
with IL-11, there was intense fluorescence signal for p-
STAT3(tyr705) that was present well inside the nucleus. Though
both activated STAT3 and PIAS1/3 were present in the nucleus
of cells treated with IL-11; there were very few co-localization
Figure 6. Expression of PIAS1/3 in JEG-3 and HTR-8/SVneo cells
following IL-11 treatment. Cell lysates were prepared after
treatment of JEG-3 and HTR-8/SVneo cells with IL-11 (200 ng/ml) for
24 h and Western blot was done for the expression of PIAS1/3 as
mentioned in Materials and Methods. Band intensities were normalized
with respect to actin and data is expressed as mean fold change in the
expression 6 SEM of PIAS1 and PIAS3 as compared to the JEG-3 control.
*p,0.05 between untreated and IL-11 treated HTR-8/SVneo cells;
#p,0.001 between untreated JEG-3 and HTR-8/SVneo cells.
doi:10.1371/journal.pone.0029745.g006
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SVneo cells, fluorescence signals for both PIAS1/3 and p-
STAT3(tyr705) were distributed into the cytoplasm as well as
inside the nucleus (Fig. 7). Upon IL-11 treatment, an increase in
the nuclear localization of p-STAT3(tyr705) as well as of PIAS1/
3 was observed (Fig. 7). The overlay of p-STAT3(tyr705), PIAS1/
3 and DAPI showed co-localization into the nucleus (Fig. 7). In
untreated cells, the co-localization of PIAS1/3 and p-STAT3(-
tyr705) was relatively less as compared to that observed after IL-
11 treatment (Fig. 7).
Discussion
Amongst several trophoblastic cell models, JEG-3 choriocarci-
noma and transformed EVT cells (HTR-8/SVneo) are the two cell
lines, which have been widely employed to investigate the invasion
and proliferation of trophoblastic cells [14]. However, as
compared to EVTs, the JEG-3 cells show major differences in
their responses to physiological ligands [15–17]. For example,
TGF b decreases the invasiveness of EVT cells in Smad3
dependent manner while, JGE-3 cells could resist that effect due
to the absence of Smad3 expression [15]. Decorin is a decidual
product that acts in a TGF b independent manner to reduce the
invasiveness of EVT but not JEG-3 cells [18–20]. Similarly, IL-11
(a decidua derived product) inhibits the invasiveness of EVTs and
HTR-8/SVneo cells but, stimulates of invasion of JEG-3 cells
[9,10]. However, the molecular basis of this differential effect is
unknown. Under such situation, it is important to understand the
mechanistic basis of the differential effects of IL-11 in these two
cells lines, as it may give cues to understand the molecular basis of
trophoblast invasion and an idea of how different extrinsic factors
control the cellular invasion.
First trimester trophoblast cells, due to intrinsic mechanism
have the invasive ability comparable to their malignant counter-
part [21]. A comparative microarray analysis of JEG-3 and HTR-
8/SVneo cells suggest that due to higher basal expression of pro-
invasive molecules as well as the signaling pathways in HTR-8/
SVneo cells, it has the higher invasive ability than that of the JEG-
3 cells. At the molecular level, the increased expression of invasion
related molecules require activation of transcription factors
through activation of diverse signaling pathways. Of several
pathways which can contribute to an increase in the invasion of
cells, HTR-8/SVneo cells have a higher basal level of activation of
STAT3 as well as ERK1/2 (Fig. 2). Activation of ERK1/2 and
STAT3 may result into the higher level of basal expression of
proteases as well as the cytokines/their receptors like IL-11, IL-32,
IL-8, IL-1, CSF1, LIFR, IGF1R and IL-4R in HTR-8/SVneo cells
as compared to JEG-3 cells.
Regulation of invasiveness of JEG-3 and HTR-8/SVneo cells
by IL-11 has remained ambiguous, as it increases the invasiveness
of JEG-3 cells while, decreases the invasiveness of HTR-8/SVneo
cells [9,10]. In the present study also, IL-11 increased the
invasiveness of JEG-3 cells while, reduced the invasiveness of
HTR-8/SVneo cells. The active expression of invasion related
Figure 7. Immunolocalization of p-STAT3 (tyr705) and PIAS1/3 in JEG-3 and HTR-8/SVneo cells following IL-11 treatment. JEG-3 and
HTR-8/SVneo cells were treated with IL-11 (200 ng/ml) for 10 min and then checked for the immunolocalization of p-STAT3 and PIAS1/3 followed by
counter staining with DAPI. In the figure sub-panels are: A; phase contrast image, B; DAPI stained cells, C; staining for PIAS1/3, D; staining for p-
STAT3(tyr705), E; co-localization of p-STAT3(tyr705) and PIAS1/3, F; merge image of the PIAS1/3, p-STAT3(tyr705) and DAPI images. Co-localization
performed for PIAS1/3 and p-STAT3(tyr705) signals using ‘‘co-localization tool’’ of the ImageJ software. Two points are considered as co-localized, if
their respective intensities are strictly higher than the threshold of their channels. Each co-localization point appears as white dot. Scale bar
represents 20 mm size.
doi:10.1371/journal.pone.0029745.g007
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the mitogen activated protein kinase (MAPK) and STAT
dependent signaling pathways [22]. Analysis of the IL-11 mediated
activation of STAT and ERK1/2 dependent signaling pathways in
both the cell lines was performed together on one blot to avoid
the experimental variations in band intensities during Western
blotting. IL-11 increased the activation of STAT3(tyr705) in both
the cell lines, which is in agreement with the published report
[9,10]. In addition to STAT3(tyr705), IL-11 also increased the
phosphorylation of STAT1(tyr701) in both the cells lines without
influencing the STAT3(ser727) phosphorylation. The major
difference in the IL-11 mediated downstream signaling in the
two cell lines was an increase in the ERK1 activation in JEG-3
cells while, a decrease in p-ERK1/2 in HTR-8/SVneo cells,
which is consistent with the observed increase and decrease in IL-
11 mediated invasiveness of JEG-3 and HTR-8/SVneo cells
respectively. The observed decrease in ERK1/2 activation in
HTR-8/SVneo cells could be due to the activation of phospha-
tases which dephosphorylate the activated ERK1/2 [23]. But, it
needs further validation to specifically pin point the molecule
which help in IL-11 mediated decrease in phosphorylation of
ERK1/2 in HTR-8/SVneo cells.
AP-1 family of transcription factors is a family of proteins which
controls the diverse biological processes like cellular proliferation,
invasion and apoptosis. Jun and Fos are the transcription factors of
AP-1 family which act as interacting partners for the activated
STAT3 and cooperate in enhancing the STAT3 mediated
transcriptional activity [24]. Upregulation of the expression of
both Jun and Fos in IL-11 treated JEG-3 cells would be of
paramount importance as they can enhance the transcriptional
activity by cooperating with STAT3 as well as by forming Jun-Jun
and Jun-Fos dimers and thereby facilitating the cellular invasion.
Reduction in the expression of Fos in HTR-8/SVneo cells treated
by IL-11 might be one of the factors associated with their reduced
invasiveness.
After analyzing the expression of transcription factors, analyses
of the IL-11 mediated expression of effector molecules (mucin-type
molecules, MMPs, inhibitors of MMPs and integrins) were carried
out in both the cell lines. Amongst mucin-type molecules, MUC1
and podoplanin (PDPN) gets upregulated in several tumors [25–
27]. IL-11 upregulated the expression of MUC1 as well as PDPN in
JEG-3 cells while; there was no significant change in their
expression in IL-11 treated HTR-8/SVneo cells. It was surprising
to note that even after STAT3 activation in HTR-8/SVneo cells,
there was no significant change in the expression of STAT3-
responsive MUC1. Under such situation, it was plausible to
analyze the expression and localization of PIAS1/3 in these cell
lines as PIAS1/3 can inhibit the transcription activity of activated
STAT3. In that direction, change in the expression of PIAS1 and
PIAS3 was analysed after treatment of both JEG-3 and HTR-8/
SVneo cells with IL-11 for 24 h. At a basal level, JEG-3 cells did
not express PIAS3 while, HTR-8/SVneo cells expressed both
PIAS1 and PIAS3 as previously observed [28]. IL-11 treatment
reduced the expression of PIAS1 in HTR-8/SVneo cells while, it
Figure 8. Schematic representation of the IL-11 mediated signaling and gene expression in JEG-3 and HTR-8/SVneo cells. IL-11
treatment to JEG-3 cells led to the activation of STAT1/3, which after dimerization moves into the nucleus. The activation of STAT3 was associated
with a transient activation of ERK1/2. Activation of STAT3(tyr705) is associated with its nuclear localization. In effect to these, an increase in the
expression of pro-invasive molecules like Jun, Fos, MUC1, PDPN, MMP23B etc have been observed. In HTR-8/SVneo cells, IL-11 treatment increases the
activation of STAT1(tyr701) and STAT3(tyr705) while, decreases the activation of ERK1/2. The increase in p-STAT3(tyr705) was associated with its
nuclear localization within 10 min of IL-11 treatment. However, upon IL-11 treatment, there was nuclear co-localization of p-STAT3(tyr705) with its
inhibitory factor PIAS1/3. This could be the reason for the decrease in the expression of Fos, MMP2, MMP3, MMP9 and MMP23B. (Solid arrows show the
confirmed findings while, dotted arrows show the hypothetical links, which needs to be validated. Name of genes written in italics have been
confirmed at the RNA level while, other have been confirmed at the protein level.).
doi:10.1371/journal.pone.0029745.g008
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decrease in the PIAS1 expression in IL-11 treated HTR-8/SVneo
cells would pose less hindrance to the p-STAT1(tyr701) directed
anti-invasive transcriptional activity. So, this might be a contrib-
utory factor for the observed IL-11 mediated reduction in the
invasiveness of HTR-8/SVneo cells. Further, extensive co-
localization points for p-STAT3(tyr705) and PIAS1/3 in IL-11
treated HTR-8/SVneo cells as compared to JEG-3 cells would
pose hindrance to the normal DNA binding and the transcrip-
tional activity of activated STAT3. This could be the reason for
the increase in the expression of STAT3-responsive MUC1 in IL-
11 treated JEG-3 cells but, not in the HTR-8/SVneo cells.
Trophoblastic cells express several proteases and their inhibitors
but, the final outcome in terms of invasive behavior is governed by
cytokine mediated shift in the fine balance between the activating
and inhibiting molecules. Several cytokines and growth factors
have been shown to increase the invasiveness of trophoblastic cells
through changes in the expression of MMPs and TIMPs [29–32].
IL-11 reduced the expression of MMP2, MMP3 and MMP9 in
HTR-8/SVneo cells but, not in JEG-3 cells. We observed an IL-
11 mediated decrease in the expression of MMP2 and MMP9 after
24 h treatment of HTR-8/SVneo cells but, in an earlier study
conducted after 48 h of IL-11 treatment, there was no significant
change in their enzymatic activity [10]. This difference could be
due to the differences in the time point for the analysis of the
expression and activity of MMPs after IL-11 treatment. No effects
of IL-11 were seen on TIMP expression in both the cell lines.
MMP23B is unique membrane anchored MMP whose expression
got significantly increased in IL-11 treated JEG-3 cells but, not
HTR-8/SVneo cells, which was reflected by microarray as well as
by qRT-PCR analysis [33,34]. Interestingly, silencing of MMP23B
expression led to a significant decrease in the invasion of JEG-3
cells at the basal as well as after IL-11 treatment. This observation
indicates MMP23B as a novel regulator of IL-11 mediated
invasion of JEG-3 cells. Beyond MMPs and TIMPs, adhesion
molecules like integrins and cadherins also play an important role
in invasion of trophoblastic cells [35,36]. Treatment of JEG-3 as
well as of HTR-8/SVneo cells with IL-11 did not show any
significant change in the expression of integrin a5, aV and a6.
However, microarray analysis of gene expression upon IL-11
treatment showed upregulation of the expression of cadherin 13
(CDH13) or H-cadherin in JEG-3 cells while, downregulation in
HTR-8/SVneo cells. It will be of interest to study the role of
CDH13 in trophoblast invasion.
From the above studies, following conclusions can be drawn. 1)
In JEG-3 cells, IL-11 mediated activation of STAT and ERK1/2
signaling pathway is responsible for the increase in the expression
of Jun, Fos, MUC1, PDPN and MMP23B, which ultimately leads to
an increase in the invasiveness of JEG-3 cells (Fig. 8). 2) IL-11
mediated decrease in HTR-8/SVneo cells invasiveness was
associated with a decrease in ERK1/2 activation, PIAS1/3
mediated activated STAT3(tyr705) sequestration and decrease in
PIAS1 expression leading to a decrease in the expression of Fos
and major families of MMPs (MMP2, MMP3, MMP9 and
MMP23B) (Fig. 8). 3) MMP23B has emerged as a novel regulator
of the IL-11 mediated invasion of JEG-3 and HTR-8/SVneo cells.
Thus, ERK1/2 and PIAS1/3 seems to be the critical factors that
may be responsible for the differential effects of IL-11 on HTR-8/
SVneo and JEG-3 cells. Taking cues from this study and that
observed in case of TGF b, it appears that despite sharing gene
expression signatures with EVT cells, the lack of crucial signaling
components like Smad3 and PIAS3 in JEG-3 cells would bring
about dramatic differences in the intricate regulatory mechanisms
in response to external stimulus. Keeping in view of the
observations described in this manuscript, it would be of interest
to extend this study to analyze the gene expression and regulatory
mechanisms associated with IL-11 mediated invasion of EVT cells.
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